Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

Oophorectomy Reduces Cancer Risk and Mortality in BRCA1 and BRCA2 Carriers

Full article: J Clin Oncol. 2014 Feb 24. [Epub ahead of print].  An epidemiologic study of 5783 women with BRCA1 or BRCA2 mutations demonstrated that preventive bilateral oophorectomy reduced the … Continue reading

April 1, 2014

Removal of Ovaries Cuts Risk of Cancer Death by 80% for those with Gene Mutation, Study Finds

“The study followed 5,783 women from seven countries with a mutation on their BRCA1 or BRCA2 gene – genes that, when working properly, suppress tumour growth – for nearly six … Continue reading

March 17, 2014

Impact of Oophorectomy on Cancer Incidence and Mortality in Women with a BRCA1 or BRCA2 Mutation

“Preventive oophorectomy was associated with an 80% reduction in the risk of ovarian, fallopian tube, or peritoneal cancer in BRCA1 or BRCA2 carriers and a 77% reduction in all-cause mortality.”  … Continue reading

March 17, 2014

Use of Cervical Mucus to Screen for Gynecological Malignancies – A Pilot Study

“The results of this study provide evidence that DNA from precursor lesions of high grade ovarian, fallopian tube and endometrial carcinomas can be detected in cervical mucus.” Ihab Lamzabi, Lela Buckingham, … Continue reading

December 12, 2013

TRINOVA-1 Signals New Direction in Ovarian Cancer

“Adding the investigational peptibody trebananib to weekly paclitaxel prolongs the time to disease progression or death in women with recurrent, advanced ovarian cancer, the phase III TRINOVA-1 trial has shown.” IMNG Medical … Continue reading

November 19, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada